Bionomics Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 3.55 M
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 3.66 M
- Revenue Growth -27.54%
- Profit Growth 340.72%
- Ebitda -11.13%
- Net Worth 12.75%
- Total Assets -5.40%
About Bionomics Lifesciences
Bionomics Lifesciences Private Limited (BLPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 October 2012 and has a history of 12 years and four months. Its registered office is in Ambala, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.55 M.
The company currently has active open charges totaling ₹3.66 M.
Mohan Sharma and Vishal Gaur serve as directors at the Company.
Company Details
- Location
Ambala, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100HR2012PTC047295
- Company No.
047295
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Oct 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Bionomics Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Sharma  | Director | 01-Oct-2012 | Current |
| Vishal Gaur | Director | 01-Oct-2012 | Current |
Financial Performance of Bionomics Lifesciences.
Bionomics Lifesciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 27.54% decrease. The company also saw a substantial improvement in profitability, with a 340.72% increase in profit. The company's net worth Soared by an impressive increase of 12.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bionomics Lifesciences?
In 2020, Bionomics Lifesciences had a promoter holding of 64.88% and a public holding of 35.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹3.66 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 0.37 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Feb 2020 | Others | ₹3.66 M | Open |
How Many Employees Work at Bionomics Lifesciences?
Unlock and access historical data on people associated with Bionomics Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bionomics Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bionomics Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.